BackBiodexa Pharmaceuticals Plc Overview

Biodexa Pharmaceuticals Plc Receivables

Biodexa Pharmaceuticals Plc's receivables is $220K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$221609.00
↓ 69.01% YoYΔ $-493391.00 vs prior year quarter

Peer trimmed avg / median

Loading

Biodexa Pharmaceuticals Plc Receivables History

Loading

Biodexa Pharmaceuticals Plc vs. peers: Receivables Comparison

Loading

Biodexa Pharmaceuticals Plc Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Biodexa Pharmaceuticals Plc (BDRX) FAQ

As of the most recent data (December 2025), BDRX shows a receivables of $220K. That compares with $720K in the prior-year period — down 69.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BDRX's receivables is now $220K (was $720K) — a 69.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Biodexa Pharmaceuticals Plc is outperforming or lagging.

Tracking BDRX's receivables over time shows whether Biodexa Pharmaceuticals Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $220K That compares with $720K in the prior-year period — down 69.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Biodexa Pharmaceuticals Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $220K) with ownership activity and broader fundamentals.

Biodexa Pharmaceuticals Plc's receivables is $220K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.